BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7617649)

  • 1. Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid.
    Arai T; Yamashita T; Urano T; Masunaga A; Itoyama S; Itoh K; Shiku H; Sugawara I
    Mod Pathol; 1995 Apr; 8(3):252-6. PubMed ID: 7617649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid.
    Arai T; Watanabe M; Onodera M; Yamashita T; Masunaga A; Itoyama S; Itoh K; Sugawara I
    Am J Pathol; 1993 Jun; 142(6):1938-44. PubMed ID: 8389529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nm23 protein expression in thyroid neoplasms.
    Royds JA; Silcocks PB; Rees RC; Stephenson TJ
    Pathologica; 1994 Jun; 86(3):240-3. PubMed ID: 7808792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
    Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
    Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of nm23-H1 gene product in thyroid, ovary, and breast cancers.
    Okubo T; Inokuma S; Takeda S; Itoyama S; Kinoshita K; Sugawara I
    Cell Biophys; 1995 Jun; 26(3):205-13. PubMed ID: 8521452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [mRNA expression of metastasis-suppressor gene nm23 in carcinoma of buccal mucosa I. Northern blotting study].
    Lu Y; Li C; Zhou Z
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):143-6. PubMed ID: 11480034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of nm23-H1 in the progression of transitional cell bladder cancer.
    Chow NH; Liu HS; Chan SH
    Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
    Tannapfel A; Katalinic A; Köckerling F; Wittekind C
    Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on expression of nm23-H1 gene in laryngeal cancer tissues].
    Wang Q; Guo M; Sun L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):198-200. PubMed ID: 9642340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
    Sarris M; Lee CS
    Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [mRNA expression of metastasis-suppressor gene nm23 in carcinoma of buccal mucosa. II. Quantitative reverse transcription PCR amplification].
    Gong L; He Z; Lu Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):147-50. PubMed ID: 11480035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].
    Huang Y; Cai S; Yu S
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):718-21. PubMed ID: 9772433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression of nm23-H1 genes with clinical prognosis in endometrial carcinoma].
    Guo C; Wei L; Fu Q
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):423-5. PubMed ID: 11360656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of antimetastatic gene nm23-H1 in epithelial ovarian cancer.
    Qian M; Feng Y; Xu L; Zheng S; Zhou X
    Chin Med J (Engl); 1997 Feb; 110(2):142-4. PubMed ID: 9594287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
    Iizuka N; Oka M; Noma T; Nakazawa A; Hirose K; Suzuki T
    Cancer Res; 1995 Feb; 55(3):652-7. PubMed ID: 7530600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The correlation between lung cancer lymph node metastasis and nm23-H1 gene mutation, mRNA expression].
    Wang G; Du C; Lin Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):340-3. PubMed ID: 10374442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.
    Gazzeri S; Brambilla E; Negoescu A; Thoraval D; Veron M; Moro D; Brambilla C
    Lab Invest; 1996 Jan; 74(1):158-67. PubMed ID: 8569178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
    Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.